GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (XCNQ:RIV) » Definitions » ROCE %
中文

RIV Capital (XCNQ:RIV) ROCE %

: -8.03% (As of Sep. 2023)
View and export this data going back to 2018. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. RIV Capital's annualized ROCE % for the quarter that ended in Sep. 2023 was -8.03%.


RIV Capital ROCE % Historical Data

The historical data trend for RIV Capital's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RIV Capital Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROCE %
Get a 7-Day Free Trial 2.70 -11.26 -50.09 -15.26 -55.90

RIV Capital Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -153.50 -6.24 -31.74 -8.83 -8.03

RIV Capital ROCE % Calculation

RIV Capital's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=-225.705/( ( (463.623 - 4.996) + (358.246 - 9.343) )/ 2 )
=-225.705/( (458.627+348.903)/ 2 )
=-225.705/403.765
=-55.90 %

RIV Capital's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=-26.792/( ( (343.252 - 7.746) + (339.414 - 7.24) )/ 2 )
=-26.792/( ( 335.506 + 332.174 )/ 2 )
=-26.792/333.84
=-8.03 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RIV Capital  (XCNQ:RIV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


RIV Capital ROCE % Related Terms

Thank you for viewing the detailed overview of RIV Capital's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


RIV Capital (XCNQ:RIV) Business Description

Traded in Other Exchanges
Address
40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2
RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.